BIOMAT Database Logo BIOMAT Database Logo

Phenylketonuria in Portugal: Genotype-phenotype correlations using molecular, biochemical, and haplotypic analyses. 2021

Filipa Ferreira, and Luísa Azevedo, and Raquel Neiva, and Carmen Sousa, and Helena Fonseca, and Ana Marcão, and Hugo Rocha, and Célia Carmona, and Sónia Ramos, and Anabela Bandeira, and Esmeralda Martins, and Teresa Campos, and Esmeralda Rodrigues, and Paula Garcia, and Luísa Diogo, and Ana Cristina Ferreira, and Silvia Sequeira, and Francisco Silva, and Luísa Rodrigues, and Ana Gaspar, and Patrícia Janeiro, and António Amorim, and Laura Vilarinho
Newborn Screening, Metabolic and Genetics Unit, Department of Human Genetics, National Institute of Health Dr Ricardo Jorge, Porto, Portugal.

The impairment of the hepatic enzyme phenylalanine hydroxylase (PAH) causes elevation of phenylalanine levels in blood and other body fluids resulting in the most common inborn error of amino acid metabolism (phenylketonuria). Persistently high levels of phenylalanine lead to irreversible damage to the nervous system. Therefore, early diagnosis of the affected individuals is important, as it can prevent clinical manifestations of the disease. In this report, the biochemical and genetic findings performed in 223 patients diagnosed through the Portuguese Neonatal Screening Program (PNSP) are presented. Overall, the results show that a high overlap exists between different types of variants and phenylalanine levels. Molecular analyses reveal a wide mutational spectrum in our population with a total of 56 previously reported variants, most of them found in compound heterozygosity (74% of the patients). Intragenic polymorphic markers were used to assess the haplotypic structure of mutated chromosomes for the most frequent variants found in homozygosity in our population (p.Ile65Thr, p.Arg158Gln, p.Leu249Phe, p.Arg261Gln, p.Val388Met, and c.1066-11G>A). Our data reveal high heterogeneity at the biochemical and molecular levels and are expected to provide a better understanding of the molecular basis of this disease and to provide clues to elucidate genotype-phenotype correlations.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D010651 Phenylalanine Hydroxylase An enzyme of the oxidoreductase class that catalyzes the formation of L-TYROSINE, dihydrobiopterin, and water from L-PHENYLALANINE, tetrahydrobiopterin, and oxygen. Deficiency of this enzyme may cause PHENYLKETONURIAS and PHENYLKETONURIA, MATERNAL. EC 1.14.16.1. Phenylalanine 4-Hydroxylase,Phenylalanine 4-Monooxygenase,4-Hydroxylase, Phenylalanine,4-Monooxygenase, Phenylalanine,Hydroxylase, Phenylalanine,Phenylalanine 4 Hydroxylase,Phenylalanine 4 Monooxygenase
D010661 Phenylketonurias A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952). Biopterin Deficiency,Dihydropteridine Reductase Deficiency Disease,Hyperphenylalaninemia, Non-Phenylketonuric,Phenylalanine Hydroxylase Deficiency Disease,BH4 Deficiency,DHPR Deficiency,Deficiency Disease, Dihydropteridine Reductase,Deficiency Disease, Phenylalanine Hydroxylase,Deficiency Disease, Phenylalanine Hydroxylase, Severe,Dihydropteridine Reductase Deficiency,Folling Disease,Folling's Disease,HPABH4C,Hyperphenylalaninaemia,Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism,Hyperphenylalaninemia, BH4-Deficient, C,Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency,Non-Phenylketonuric Hyperphenylalaninemia,Oligophrenia Phenylpyruvica,PAH Deficiency,PKU, Atypical,Phenylalanine Hydroxylase Deficiency,Phenylalanine Hydroxylase Deficiency Disease, Severe,Phenylketonuria,Phenylketonuria I,Phenylketonuria II,Phenylketonuria Type 2,Phenylketonuria, Atypical,Phenylketonuria, Classical,QDPR Deficiency,Quinoid Dihydropteridine Reductase Deficiency,Tetrahydrobiopterin Deficiency,Atypical PKU,Atypical Phenylketonuria,Biopterin Deficiencies,Classical Phenylketonuria,Deficiency, BH4,Deficiency, Biopterin,Deficiency, DHPR,Deficiency, Dihydropteridine Reductase,Deficiency, PAH,Deficiency, Phenylalanine Hydroxylase,Deficiency, QDPR,Deficiency, Tetrahydrobiopterin,Disease, Folling,Disease, Folling's,Hyperphenylalaninemia, Non Phenylketonuric,Non Phenylketonuric Hyperphenylalaninemia,Non-Phenylketonuric Hyperphenylalaninemias
D011174 Portugal A country in southwestern Europe, bordering the North Atlantic Ocean, west of Spain. The capital is Lisbon. Madeira Island,Portuguese Republic
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype

Related Publications

Filipa Ferreira, and Luísa Azevedo, and Raquel Neiva, and Carmen Sousa, and Helena Fonseca, and Ana Marcão, and Hugo Rocha, and Célia Carmona, and Sónia Ramos, and Anabela Bandeira, and Esmeralda Martins, and Teresa Campos, and Esmeralda Rodrigues, and Paula Garcia, and Luísa Diogo, and Ana Cristina Ferreira, and Silvia Sequeira, and Francisco Silva, and Luísa Rodrigues, and Ana Gaspar, and Patrícia Janeiro, and António Amorim, and Laura Vilarinho
Genotype-phenotype correlations in phenylketonuria.
July 1993, Clinica chimica acta; international journal of clinical chemistry,
Filipa Ferreira, and Luísa Azevedo, and Raquel Neiva, and Carmen Sousa, and Helena Fonseca, and Ana Marcão, and Hugo Rocha, and Célia Carmona, and Sónia Ramos, and Anabela Bandeira, and Esmeralda Martins, and Teresa Campos, and Esmeralda Rodrigues, and Paula Garcia, and Luísa Diogo, and Ana Cristina Ferreira, and Silvia Sequeira, and Francisco Silva, and Luísa Rodrigues, and Ana Gaspar, and Patrícia Janeiro, and António Amorim, and Laura Vilarinho
Variations in genotype-phenotype correlations in phenylketonuria patients.
January 2010, Genetics and molecular research : GMR,
Filipa Ferreira, and Luísa Azevedo, and Raquel Neiva, and Carmen Sousa, and Helena Fonseca, and Ana Marcão, and Hugo Rocha, and Célia Carmona, and Sónia Ramos, and Anabela Bandeira, and Esmeralda Martins, and Teresa Campos, and Esmeralda Rodrigues, and Paula Garcia, and Luísa Diogo, and Ana Cristina Ferreira, and Silvia Sequeira, and Francisco Silva, and Luísa Rodrigues, and Ana Gaspar, and Patrícia Janeiro, and António Amorim, and Laura Vilarinho
[Correlations between genotype and phenotype in children with phenylketonuria?].
May 1991, Archives francaises de pediatrie,
Filipa Ferreira, and Luísa Azevedo, and Raquel Neiva, and Carmen Sousa, and Helena Fonseca, and Ana Marcão, and Hugo Rocha, and Célia Carmona, and Sónia Ramos, and Anabela Bandeira, and Esmeralda Martins, and Teresa Campos, and Esmeralda Rodrigues, and Paula Garcia, and Luísa Diogo, and Ana Cristina Ferreira, and Silvia Sequeira, and Francisco Silva, and Luísa Rodrigues, and Ana Gaspar, and Patrícia Janeiro, and António Amorim, and Laura Vilarinho
Toward mechanistic models for genotype-phenotype correlations in phenylketonuria using protein stability calculations.
April 2019, Human mutation,
Filipa Ferreira, and Luísa Azevedo, and Raquel Neiva, and Carmen Sousa, and Helena Fonseca, and Ana Marcão, and Hugo Rocha, and Célia Carmona, and Sónia Ramos, and Anabela Bandeira, and Esmeralda Martins, and Teresa Campos, and Esmeralda Rodrigues, and Paula Garcia, and Luísa Diogo, and Ana Cristina Ferreira, and Silvia Sequeira, and Francisco Silva, and Luísa Rodrigues, and Ana Gaspar, and Patrícia Janeiro, and António Amorim, and Laura Vilarinho
Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome.
April 1999, American journal of medical genetics,
Filipa Ferreira, and Luísa Azevedo, and Raquel Neiva, and Carmen Sousa, and Helena Fonseca, and Ana Marcão, and Hugo Rocha, and Célia Carmona, and Sónia Ramos, and Anabela Bandeira, and Esmeralda Martins, and Teresa Campos, and Esmeralda Rodrigues, and Paula Garcia, and Luísa Diogo, and Ana Cristina Ferreira, and Silvia Sequeira, and Francisco Silva, and Luísa Rodrigues, and Ana Gaspar, and Patrícia Janeiro, and António Amorim, and Laura Vilarinho
Gaucher disease: molecular heterogeneity and phenotype-genotype correlations.
August 1989, American journal of human genetics,
Filipa Ferreira, and Luísa Azevedo, and Raquel Neiva, and Carmen Sousa, and Helena Fonseca, and Ana Marcão, and Hugo Rocha, and Célia Carmona, and Sónia Ramos, and Anabela Bandeira, and Esmeralda Martins, and Teresa Campos, and Esmeralda Rodrigues, and Paula Garcia, and Luísa Diogo, and Ana Cristina Ferreira, and Silvia Sequeira, and Francisco Silva, and Luísa Rodrigues, and Ana Gaspar, and Patrícia Janeiro, and António Amorim, and Laura Vilarinho
Molecular Genetics of Hypophosphatasia and Phenotype-Genotype Correlations.
January 2015, Sub-cellular biochemistry,
Filipa Ferreira, and Luísa Azevedo, and Raquel Neiva, and Carmen Sousa, and Helena Fonseca, and Ana Marcão, and Hugo Rocha, and Célia Carmona, and Sónia Ramos, and Anabela Bandeira, and Esmeralda Martins, and Teresa Campos, and Esmeralda Rodrigues, and Paula Garcia, and Luísa Diogo, and Ana Cristina Ferreira, and Silvia Sequeira, and Francisco Silva, and Luísa Rodrigues, and Ana Gaspar, and Patrícia Janeiro, and António Amorim, and Laura Vilarinho
Relationship between mutation genotype and biochemical phenotype in a heterogeneous Spanish phenylketonuria population.
January 1997, European journal of human genetics : EJHG,
Filipa Ferreira, and Luísa Azevedo, and Raquel Neiva, and Carmen Sousa, and Helena Fonseca, and Ana Marcão, and Hugo Rocha, and Célia Carmona, and Sónia Ramos, and Anabela Bandeira, and Esmeralda Martins, and Teresa Campos, and Esmeralda Rodrigues, and Paula Garcia, and Luísa Diogo, and Ana Cristina Ferreira, and Silvia Sequeira, and Francisco Silva, and Luísa Rodrigues, and Ana Gaspar, and Patrícia Janeiro, and António Amorim, and Laura Vilarinho
Familial hypertrophic cardiomiopathy: molecular basis and genotype-phenotype correlations.
October 1998, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,
Filipa Ferreira, and Luísa Azevedo, and Raquel Neiva, and Carmen Sousa, and Helena Fonseca, and Ana Marcão, and Hugo Rocha, and Célia Carmona, and Sónia Ramos, and Anabela Bandeira, and Esmeralda Martins, and Teresa Campos, and Esmeralda Rodrigues, and Paula Garcia, and Luísa Diogo, and Ana Cristina Ferreira, and Silvia Sequeira, and Francisco Silva, and Luísa Rodrigues, and Ana Gaspar, and Patrícia Janeiro, and António Amorim, and Laura Vilarinho
Peroxisomal disorders. Molecular defects, genotype-phenotype correlations and therapy.
January 1999, Le Journal medical libanais. The Lebanese medical journal,
Copied contents to your clipboard!